DuPont Nutrition & Health and Lonza Consumer Health & Nutrition are to join forces to manufacture and supply human milk oligosaccharide (HMO) in a deal that looks to meet rising demand in a €44bn global infant nutrition sector.
Glanbia plc released its 2018 financials this week, revealing growing profits on the back of a few high-profile acquisitions. The nutritional ingredients and dairy business is dipping into the non-dairy sector and reorganizing its board of directors in...
Microbiome-based personalized food start-up Viome has entered into an agreement to buy fellow personalized nutrition company Habit from Campbell Soup Company.
South Korean organic produce distributor Ewha Company is planning to go international with its food brand Nature Food's signature red ginseng product, having China firmly in its sights.
The chief executive of Irish nutrition company Glanbia has revealed the firm has begun stockpiling supplies in the UK in the likely event of a no-deal Brexit.
The Irish government is to move ahead with plans to tax food supplements such as probiotics and Omega 3 fatty acids on the 1st March with the publication of guidance on the impending changes.
Pfizer and GlaxoSmithKline are merging their consumer health units, bringing the two pharma giants’ dietary supplement and over-the-counter brands into what analysts are calling “the world’s largest consumer health company.”
US nutrition data firm Medtronic is to acquire Nutrino Health in a deal that combines both firms’ expertise in nutritional intervention to address the threat of metabolic conditions such as diabetes.
Proposed plans could see food supplements such as probiotics and Omega 3 fatty acids subject to a VAT rate of up to 23% in moves set out by the Irish government in time for January next year.
Science in Sport (SiS) has revealed plans to acquire fellow sports nutrition firm PhD Nutrition in a €36.8m (£32m) deal, with the majority financed by a share offering subject to conditions.
French microbiome biotechnology firm Enterome has signed a global licensing, co-development and co-promotion agreement with major pharmaceutical player Takeda.
Royal DSM has announced plans to expand vitamin B2 production capacity at its facility in Grenzach, Germany, in a move intended to meet rising demand across the food and dietary supplement markets.
Aspen Pharmacare Holdings Limited, a global pharmaceutical company based in South Africa, has announced today, in conjunction with the announcement of its annual results for the year ended June 30, 2018, that it has concluded an agreement to divest of...
The UK Government’s clampdown on rogue health supplement firms scored a victory in the High Court as a company was ordered into liquidation after taking advantage of elderly and vulnerable customers.
